a77 1726, the active metabolite of leflunomide, attenuates lupus nephritis by promoting the development of regulatory t cells and inhibiting il-17-producing double negative t cells：a77 1726，来氟米特的活性代谢产物，减轻狼疮性肾炎通过促进调节性t细胞发育和抑制体内的双阴性t细胞.pdfVIP

Clinical Immunology (2015) 157, 166–174 a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m C l i n i c a l I m m u n o l o g y w w w . e l s e v i e r . c o m / l o c a t e / y c l i m A77 1726, the active metabolite of leflunomide, attenuates lupus nephritis by promoting the development of regulatory T cells and inhibiting IL-17-producing double negative T cells Guilin Qiao a , Lifen Yang a , Zhenping Li a , James W. Wil